# DLL3-Targeted PET/CT in Small Cell Lung Cancer

> **NCT07677787** · NA · RECRUITING · sponsor: **The First Affiliated Hospital of Xiamen University** · enrollment: 20 (estimated)

## Conditions studied

- PET/CT
- Small Cell Lung Cancer ( SCLC )
- DLL3-targeted PET/CT
- Delta-like Protein 3

## Interventions

- **DIAGNOSTIC_TEST:** conventional imaging (CT, MRI or 18F-FDG PET/CT), DLL3-targeted PET/CT

## Key facts

- **NCT ID:** NCT07677787
- **Lead sponsor:** The First Affiliated Hospital of Xiamen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-09
- **Primary completion:** 2028-05-31
- **Final completion:** 2028-05-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07677787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07677787, "DLL3-Targeted PET/CT in Small Cell Lung Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07677787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*